Xingyi Pan

Xingyi Pan is a Phd Candidate at Johns Hopkins Medicine, where they study tumor macrophage interaction in pancreatic cancer to develop innovative cancer immunotherapy that targeting macrophages. Xingyi also works on developing a novel epigenetic cancer vaccine for pancreatic cancer treatment. Xingyi has also served as the Director Of Education for the Johns Hopkins Graduate Consulting Club and as a Marketing Ambassador for the Global Biotech Revolution. Xingyi is currently a Project Team Associate for COPi Group and a Leader of Tomorrow for the Global Biotech Revolution.

Xingyi Pan received a Doctor of Philosophy in Cellular & Molecular Medicine from The Johns Hopkins University School of Medicine in 2021. They also hold a Clinical Trial Certificate from The Johns Hopkins University - Bloomberg School of Public Health in Clinical Trial Research, which they received in 2020. Prior to that, they completed a Bachelor of Science in Biochemistry from the University of Michigan in 2016. During their time at the University of Michigan, Xingyi was involved in several extracurricular activities, including James B. Angell Scholars, University Honors, and Peer Advisor at the Newnan Academic Advising Center.